Term ends May 8, 2027 · High confidence
20-year base term ends May 8, 2027
Held by University of Rochester
Filed Nov 28, 2012 as application 13/686,952 · Granted Jan 13, 2015
Base term, 20 years from filing
Today
2007
2027
Clock starts
May 8, 2007
May 8, 2007
Term ends
May 8, 2027
May 8, 2027
Granted
Jan 13, 2015
Jan 13, 2015
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
13
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 8, 2007, when application 11/745,746, the earliest non-provisional in its chain, was filed (this one was filed Nov 28, 2012) | May 8, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 8, 2027 | High confidence |
This family
| Application 60/817,027 | Provisional application no patent term | no patent term |
| Application 11/745,746 | Abandoned not computed | not computed |
| Application PCT/US2007/071538 | PCT application no patent term | no patent term |
| US 7,789,910 | In force Aug 2027 | Aug 2027 |
| Application PCT/US2008/083076 | PCT application no patent term | no patent term |
| US 8,337,553 | In force Sep 2027 | Sep 2027 |
| US 8,932,352 | this patent May 2027 | May 2027 |
| US 10,543,076 | In force May 2027 | May 2027 |
8 of 13 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 4, 2013 Reel 31156, frame 508 | Bausch & Lomb Incorporated | Goldman Sachs Lending Partners LLC, as Collateral Agent | Security Agreement |
| Aug 14, 2014 Reel 33538, frame 812 | Bausch & Lomb Incorporated | University of Rochester | Assignment of Assignor's Interest |
| Sep 18, 2014 Reel 33770, frame 556 | Ding, Li | University of Rochester | Assignment of Assignor's Interest |
| Sep 18, 2014 Reel 33771, frame 19 | Knox, Wayne | Knox, Wayne | Assignment of Assignor's Interest |
| Sep 18, 2014 Reel 33771, frame 135 | Kunzler, Jay Friedrich; Jani, Dharmendra M. | Bausch & Lomb Incorporated | Assignment of Assignor's Interest |
| Oct 22, 2014 Reel 34032, frame 930 | Knox, Wayne | University of Rochester | Corrective Assignment to Correct the Assignee Name and Assignee Address Previously Recorded at Reel: 033771 Frame: 0019. Assignor(S) Hereby Confirms the Assignment. |
| Jan 9, 2015 Reel 34749, frame 689 | Goldman Sachs Lending Partners, LLC | Barclays Bank PLC, as Successor Agent | Notice of Succession of Agency |
| Apr 8, 2015 Reel 35362, frame 805 | Kunzler, Jay F.; Jani, Dharmendra; Pinto, Candido D. | Bausch & Lomb Incorporated | Assignment of Assignor's Interest |
| Apr 8, 2015 Reel 35362, frame 899 | Knox, Wayne H.; Ding, Li | University of Rochester | Assignment of Assignor's Interest |
| Feb 5, 2019 Reel 48259, frame 134 | Barclays Bank PLC, as Collateral Agent | Bausch & Lomb Incorporated | Release of Security Interest in Specified Patents |
| Apr 8, 2025 Reel 70778, frame 199 | Barclays Bank PLC, as Collateral Agent | Solta Medical, Inc.; Precision Dermatology, Inc.; Bausch Health Ireland Limited (F/K/A/ Valeant Pharmaceuticals Ireland Limited); Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Medicis Pharmaceutical Corporation; Humax Pharmaceutical S.A.; Solta Medical Ireland Limited; Bausch & Lomb Mexico, S.A. de C.V.; Bausch+lomb Ops B.V.; Bausch Health Americas, Inc.; Bausch Health Companies Inc.; Bausch Health Holdco Limited; Bausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC); Bausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia); Bausch Health US, LLC; Bausch Health, Canada Inc. / Sante Bausch, Canada Inc.; ICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.); Orapharma, Inc.; Przedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.); Solta Medical Dutch Holdings B.V.; V-Bac Holding Corp.; VRX Holdco LLC; 1261229 B.C. Ltd.; 1530065 B.C. Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Precision Dermatology, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Ireland Limited (F/K/A/ Valeant Pharmaceuticals Ireland Limited) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Salix Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Salix Pharmaceuticals, Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Santarus, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Medicis Pharmaceutical Corporation | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Humax Pharmaceutical S.A. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical Ireland Limited | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch & Lomb Mexico, S.A. de C.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch+lomb Ops B.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Americas, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Companies Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Holdco Limited | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health US, LLC | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health, Canada Inc. / Sante Bausch, Canada Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | ICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Orapharma, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Przedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical Dutch Holdings B.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | V-Bac Holding Corp. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | VRX Holdco LLC | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | 1261229 B.C. Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | 1530065 B.C. Ltd. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2027
Term ends May 8, 2027. No further fees fall due before then
Citations
19
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.